TrialClinical cancer research : an official journal of the American Association for Cancer Research2009

An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.

Glenn Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.